Showing results (381-390 of 400) with videos related to
Sort By:
Pageof 40
Frontiers in Neurology|August 22, 2022
Deep learning-based relapse prediction of neuromyelitis optica spectrum disorder with anti-aquaporin-4 antibodyLiang Wang, Lei Du, Qinying Li, et al.Therapeutic Advances in Neurological Disorders|April 15, 2024
Treatment algorithms of relapsing multiple sclerosis: an exploration based on the available disease-modifying therapies in ChinaJun Guo, Jiayong Wu, Lihua Wang, et al.Frontiers in Immunology|April 18, 2022
Neuromyelitis Optica Spectrum Disorder With Anti-Aquaporin-4 Antibody: Outcome Prediction ModelsLiang Wang, Lei Du, Qinying Li, et al.Blood|March 17, 2018
Genetic landscape of hepatitis B virus-associated diffuse large B-cell lymphomaWeicheng Ren, Xiaofei Ye, Hong Su, et al.Nature Biotechnology|October 7, 2025
Folding-mediated secretion of pure bispecific antibodiesCholpon Tilegenova, Tun Liu, Qian Zhao, et al.Blood|March 16, 2025
Genetic and epigenetic mechanisms of GPRC5D loss after anti-GPRC5D CAR T-cell therapy in multiple myelomaSha Ma, Jieyun Xia, Miao Zhang, et al.Eclinicalmedicine|September 2, 2025
Efficacy and safety of tazemetostat, an EZH2 inhibitor, in Chinese patients with relapsed/refractory follicular lymphoma: a multicentre, single-arm, phase 2 studyJunning Cao, Guangliang Chen, Lihua Qiu, et al.Cancer Letters|June 22, 2024
CDK4/6 inhibition augments anti-tumor efficacy of XPO1 inhibitor selinexor in natural killer/T-cell lymphomaYali Wang, Jianfeng Chen, Yan Gao, et al.Nature Metabolism|June 27, 2022
Impaired oxygen-sensitive regulation of mitochondrial biogenesis within the von Hippel-Lindau syndromeShuijie Li, Wenyu Li, Juan Yuan, et al.Haematologica|January 18, 2024
Phase I study of the Syk inhibitor sovleplenib in relapsed or refractory mature B-cell tumorsYuqin Song, Junning Cao, Qingyuan Zhang, et al.Pageof 40